n
|
|
144 |
Antiphospholipid antibodies (%)
|
No |
141 (97.9) |
|
Yes |
3 (2.1) |
Primary cancer organ (%)
|
Gynecological |
23 (16.0) |
|
Lung |
41 (28.5) |
|
Other GIT cancers |
19 (13.2) |
|
Others |
33 (22.9) |
|
Pancreas |
28 (19.4) |
Lung vs. other cancers (%)
|
Others |
103 (71.5) |
|
Lung cancer |
41 (28.5) |
Pathology (%)
|
Adenocarcinoma |
93 (64.6) |
|
Hematopoietic |
6 (4.2) |
|
Others |
38 (26.4) |
|
Sarcoma |
1 (0.7) |
|
SCC |
6 (4.2) |
Adenocarcinoma vs. other pathologies (%)
|
Other pathologies |
51 (35.4) |
|
Adenocarcinoma |
93 (64.6) |
Organ of metastasis (n = 97) (%)
|
Bone |
5 (5.2) |
|
Brain |
3 (3.1) |
|
Liver |
23 (23.7) |
|
Lung |
7 (7.2) |
|
Lymph nodes |
22 (22.7) |
|
Multiple |
25 (25.8) |
|
Others |
12 (12.4) |
Metastasis (n = 141) (%)
|
Non-metastatic |
43 (30.7) |
|
Metastatic |
97 (69.3) |
Marantic presentation before diagnosis of cancer (n = 125) (%)
|
Known cancer case |
42 (33.6) |
|
Marantic as first presentation |
83 (66.4) |
Interval diagnosis (months) (mean (SD)
|
|
6.24 (25.51) |
Age (median (IQR))
|
|
60.00 (49.75, 66.00) |
Sex (%)
|
Females |
81 (56.25) |
|
Males |
63 (43.75) |
COPD (n = 52) (%)
|
No |
49 (94.2) |
|
Yes |
3 (5.8) |
Smoking (n = 56) (%)
|
No |
43 (76.8) |
|
Yes |
13 (23.2) |
Diabetes (n = 52) (%)
|
No |
43 (82.7) |
|
Yes |
9 (17.3) |
Obesity (n = 53) (%)
|
No |
52 (98.1) |
|
Yes |
1 (1.9) |
Dyslipidemia (n = 54) (%)
|
No |
46 (85.2) |
|
Yes |
8 (14.8) |
Hypertension (n = 56) (%)
|
No |
36 (64.3) |
|
Yes |
20 (35.7) |
Embolization event at presentation (n = 132) (%)
|
No |
15 (11.4) |
|
Yes |
117 (88.6) |
Embolic event after diagnosis (n = 125) (%)
|
No |
76 (60.8) |
|
Yes |
49 (39.2) |
Incidental finding of NBTE (%)
|
No |
132 (91.7) |
|
Yes |
12 (8.3) |
Postmortem diagnosis of NBTE (%)
|
No |
95 (66.0) |
|
Yes |
49 (34.0) |
Position of vegetation (n = 132) (%)
|
Aortic |
48 (36.4) |
|
Left atrium |
1 (0.8) |
|
Mitral |
62 (47.0) |
|
Multiple |
21 (15.9) |
Valve insufficiency (n = 89) (%)
|
No |
28 (31.5) |
|
Yes |
61 (68.5) |
Valve stenosis (n = 90) (%)
|
No |
81 (90.0) |
|
Yes |
9 (10.0) |
Underwent intervention (%)
|
No |
123 (85.4) |
|
Yes |
21 (14.6) |
Type of surgery (%)
|
Excision of vegetation |
5 (3.5) |
|
None |
123 (85.4) |
|
Replacement |
16 (11.1) |
Presenting symptoms (n = 139) (%)
|
Cardiological |
6 (4.5) |
|
Neurological |
96 (72.7) |
|
Others |
7 (5.3) |
|
Respiratory |
13 (9.8) |
|
Vascular |
10 (7.6) |
Death (%)
|
No |
47 (32.6) |
|
Yes |
97 (67.4) |
Time to death (days) (median (IQR))
|
|
15.40 (2.73, 56.00) |